Drug intelligence / Profile preview

autologous bone marrow-derived mesenchymal stem cells (University of Sao Paulo)

Development stage: Unknown
Lead developer: Universidade de São Paulo
Modality: Stem Cell Therapies → Cell Therapies
Administration: Local

Overview

This is an autologous cell therapy consisting of bone marrow-derived mesenchymal stem cells (BMSCs) developed by the University of São Paulo. It is being investigated as a biological adjuvant to enhance healing during arthroscopic rotator cuff repair, specifically for patients with isolated full-thickness supraspinatus tears. The cells are harvested from the patient's bone marrow and applied at the tendon-bone interface at the end of the surgical procedure to promote regenerative healing and reduce the risk of retears. The therapy is currently being evaluated in a Phase 2 randomized prospective study to assess its impact on tendon integrity and clinical outcomes.

Other names: mesenchymal stem cellsBMSCsbone marrow-derived mesenchymal stem cells

Beyond the preview

Go deeper on autologous bone marrow-derived mesenchymal stem cells (University of Sao Paulo).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous bone marrow-derived mesenchymal stem cells (University of Sao Paulo).

Explore the full profile